1. Home
  2. EMBC vs GAU Comparison

EMBC vs GAU Comparison

Compare EMBC & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • GAU
  • Stock Information
  • Founded
  • EMBC 1924
  • GAU 1999
  • Country
  • EMBC United States
  • GAU Canada
  • Employees
  • EMBC N/A
  • GAU N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • GAU
  • Sector
  • EMBC Health Care
  • GAU
  • Exchange
  • EMBC Nasdaq
  • GAU Nasdaq
  • Market Cap
  • EMBC 782.5M
  • GAU 731.5M
  • IPO Year
  • EMBC N/A
  • GAU N/A
  • Fundamental
  • Price
  • EMBC $14.01
  • GAU $2.54
  • Analyst Decision
  • EMBC Buy
  • GAU Strong Buy
  • Analyst Count
  • EMBC 2
  • GAU 2
  • Target Price
  • EMBC $18.50
  • GAU $3.00
  • AVG Volume (30 Days)
  • EMBC 318.1K
  • GAU 3.7M
  • Earning Date
  • EMBC 11-25-2025
  • GAU 11-06-2025
  • Dividend Yield
  • EMBC 4.28%
  • GAU N/A
  • EPS Growth
  • EMBC 18.26
  • GAU N/A
  • EPS
  • EMBC 1.42
  • GAU N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • GAU $309,575,000.00
  • Revenue This Year
  • EMBC N/A
  • GAU $80.41
  • Revenue Next Year
  • EMBC N/A
  • GAU $43.45
  • P/E Ratio
  • EMBC $9.87
  • GAU N/A
  • Revenue Growth
  • EMBC N/A
  • GAU 223.63
  • 52 Week Low
  • EMBC $9.20
  • GAU $1.00
  • 52 Week High
  • EMBC $21.48
  • GAU $3.12
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 49.90
  • GAU 48.49
  • Support Level
  • EMBC $13.75
  • GAU $2.40
  • Resistance Level
  • EMBC $14.43
  • GAU $2.84
  • Average True Range (ATR)
  • EMBC 0.43
  • GAU 0.16
  • MACD
  • EMBC 0.03
  • GAU -0.05
  • Stochastic Oscillator
  • EMBC 64.14
  • GAU 20.98

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About GAU Galiano Gold Inc.

Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.

Share on Social Networks: